Sinomenine, an Alkaloid Derived from Sinomenium acutum Potentiates Pentobarbital-Induced Sleep Behaviors and Non-Rapid Eye Movement (NREM) Sleep in Rodents|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Sinomenium acutum has been long used in the preparations of traditional medicine in Japan, China and Korea for the treatment of various disorders including rheumatism, fever, pulmonary diseases and mood disorders. Recently, it was reported that Sinomenium acutum, has sedative and anxiolytic effects mediated by GABA-ergic systems. These experiments were performed to investigate whether sinomenine (SIN), an alkaloid derived from Sinomenium acutum enhances pentobarbital-induced sleep via γ-aminobutyric acid (GABA)-ergic systems, and modulates sleep architecture in mice. Oral administration of SIN (40 mg/kg) markedly reduced spontaneous locomotor activity, similar to diazepam (a benzodiazepine agonist) in mice. SIN shortened sleep latency, and increased total sleep time in a dose-dependent manner when co-administrated with pentobarbital (42 mg/kg, i.p.). SIN also increased the number of sleeping mice and total sleep time by concomitant administration with the sub-hypnotic dosage of pentobarbital (28 mg/kg, i.p.). SIN reduced the number of sleep-wake cycles, and increased total sleep time and non-rapid eye movement (NREM) sleep. In addition, SIN also increased chloride influx in the primary cultured hypothalamic neuronal cells. Furthermore, protein overexpression of glutamic acid decarboxylase (GAD65/67) and GABAA receptor subunits by western blot were found, being activated by SIN. In conclusion, SIN augments pentobarbital-induced sleeping behaviors through GABAA-ergic systems, and increased NREM sleep. It could be a candidate for the treatment of insomnia.

번역하기

참고문헌 (Reference)

1 Tillakaratne, N. J., "γ-Aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues" 112 : 247-263, 1995

2 Bu, D. F., "Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene" 89 : 2115-2119, 1992

3 Crestani, F., "Trace fear conditioning involves hippocampal α5 GABAA receptors" 99 : 8980-8985, 2002

4 Gottesmann, C., "The transition from slow-wave sleep to paradoxical sleep: evolving facts and concepts of the neurophysiological processes underlying the intermediate stage of sleep" 20 : 367-387, 1996

5 Datta, S., "The rat as an experimental model for sleep neurophysiology" 114 : 1239-1244, 2000

6 Rao, S., "The effect of sinomenine in diabetic neuropathic pain mediated by the P2X3 receptor in dorsal root ganglia" 13 : 227-235, 2017

7 Sieghart, W., "Structure and pharmacology of γ-aminobutyric acidA receptor subtypes" 47 : 181-234, 1995

8 Trachsel, L., "Sleep continuity and the REM-nonREM cycle in the rat under baseline conditions and after sleep deprivation" 49 : 575-580, 1991

9 McKernan, R. M., "Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype" 3 : 587-592, 2000

10 Ma, Y., "Sanjoinine A isolated from Zizyphi Spinosi Semen augments pentobarbital-induced sleeping behaviors through the modification of GABA-ergic systems" 30 : 1748-1753, 2007